CRISPR

CRISPR1-nos2b

ID
ZDB-CRISPR-201023-1
Name
CRISPR1-nos2b
Previous Names
None
Target
Sequence
5' - GCGTTGGTATGCATTGCCTG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
sou2 nos2b
Expression
Gene expression in Wild Types + CRISPR1-nos2b
No data available
Phenotype
Phenotype resulting from CRISPR1-nos2b
No data available
Phenotype of all Fish created by or utilizing CRISPR1-nos2b
Phenotype Fish Conditions Figures
intestine nitric oxide decreased amount, abnormal nos2bsou2/sou2 standard conditions Fig. 1 with image from Huang et al., 2024
whole organism swimming behavior increased process quality, abnormal nos2bsou2/sou2 (AB) standard conditions Fig. 2Fig. 4 from Gao et al., 2020
periventricular grey zone decreased thickness, abnormal nos2bsou2/sou2 (AB) standard conditions Fig. 3 from Gao et al., 2020
whole organism swimming behavior process quality, ameliorated nos2bsou2/sou2 (AB) chemical treatment by environment: methylphenidate hydrochloride Fig. 4 from Gao et al., 2020
brain homer1b expression increased amount, abnormal nos2bsou2/sou2 (AB) chemical treatment by environment: sodium nitroprusside Fig. 4 from Gao et al., 2020
brain sypb expression decreased amount, abnormal nos2bsou2/sou2 (AB) standard conditions Fig. 3 from Gao et al., 2020
whole organism swimming behavior process quality, ameliorated nos2bsou2/sou2 (AB) chemical treatment by environment: sodium nitroprusside Fig. 4 from Gao et al., 2020
brain sypb expression increased amount, abnormal nos2bsou2/sou2 (AB) chemical treatment by environment: sodium nitroprusside Fig. 4 from Gao et al., 2020
brain homer1b expression increased amount, abnormal nos2bsou2/sou2 (AB) chemical treatment by environment: methylphenidate hydrochloride Fig. 4 from Gao et al., 2020
female organism optic tectum decreased thickness, abnormal nos2bsou2/sou2 (AB) standard conditions Fig. 3 from Gao et al., 2020
brain homer1b expression decreased amount, abnormal nos2bsou2/sou2 (AB) standard conditions Fig. 3 from Gao et al., 2020
brain decreased weight, abnormal nos2bsou2/sou2 (AB) standard conditions Fig. 3 from Gao et al., 2020
brain decreased width, abnormal nos2bsou2/sou2 (AB) standard conditions Fig. 3 from Gao et al., 2020
whole organism nos2b expression decreased amount, abnormal nos2bsou2/sou2 (AB) standard conditions Fig. 1 from Gao et al., 2020
brain sypb expression increased amount, abnormal nos2bsou2/sou2 (AB) chemical treatment by environment: methylphenidate hydrochloride Fig. 4 from Gao et al., 2020
intestine adgrf6 expression decreased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine cd109 expression decreased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine c6.1 expression increased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine host-mediated modulation of intestinal microbiota composition process quality, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 2 with imageFig. 3 with image from Huang et al., 2024
intestine igsf9ba expression increased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine cfb expression increased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine trafd1 expression decreased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine c8g expression increased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine rgs13a expression decreased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine c5 expression increased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine ier2a expression decreased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine nitric oxide decreased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 1 with image from Huang et al., 2024
intestine il26 expression increased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine cd28 expression decreased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine ikbke expression decreased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine il13 expression increased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine c3a.1 expression increased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine cd36 expression decreased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
intestine cfd expression decreased amount, abnormal nos2asou16/sou16; nos2bsou2/sou2 standard conditions Fig. 6 with image from Huang et al., 2024
Citations